In a model of ligand-induced periodontal disease, treatment with a PPARδ nuclear receptor agonist (GW0742) produced less inflammatory cytokines, inducible nitric oxide synthase (iNOS) enzyme, apopotosis, and tissue damage, indicating that the receptor mediates anti-inflammatory events. This evidence concerns the gene NOS2 and periodontal disorder.